Company Filing History:
Years Active: 1985-1995
Title: The Innovative Contributions of Terry T. Kensler
Introduction
Terry T. Kensler, a distinguished inventor based in Evansville, Indiana, has made significant contributions to the field of pharmaceuticals. With a portfolio that includes four patents, she continues to innovate and improve formulations that impact patient care and treatment options.
Latest Patents
Among her most recent inventions is the **Lyophilized Cyclophosphamide**, which is a lyophilized pharmaceutical solid composition. This composition contains cyclophosphamide and is designed for reconstitution with water to provide a solution for both oral and parenteral administration. The formulation demonstrates improved stability, solubility characteristics, and an enhanced appearance compared to existing dry powder premix compositions of cyclophosphamide. The composition consists of approximately 20 parts by weight of cyclophosphamide, about 1.25 to 2 parts by weight of water, and between 10 to 85 parts by weight of an excipient, primarily mannitol. The processes for producing this innovative composition have been thoroughly disclosed in her patent filings.
Career Highlights
Throughout her career, Terry has been associated with notable companies including Mead Johnson & Company and Bristol-Myers Company. Her work at these organizations has allowed her to translate her innovative ideas into functional pharmaceutical products, making a significant impact in the industry.
Collaborations
Terry has collaborated with esteemed professionals such as Robert L. Alexander and Robert J. Bequette. These partnerships have fostered a rich environment for innovation and development within her field.
Conclusion
Terry T. Kensler is an exemplary inventor whose work continues to influence the pharmaceutical industry positively. Her commitment to developing superior formulations like the lyophilized cyclophosphamide reflects her dedication to enhancing treatment standards and patient outcomes. As she continues to innovate, her contributions will undoubtedly inspire future advancements in pharmaceuticals.